Marian Montanha, narrates her blog written for the Dementia Researcher website.
In this blog, Marian explains how biomarkers are used in dementia trials, particularly in diagnosing and tracking Alzheimer’s disease. She reflects on how current diagnostic tools fall short and explores how biomarker research could enable earlier and more accurate detection. Marian also shares her experience supporting participants in these studies, highlighting both the burden and the value of their involvement. It’s a clear-eyed look at a tool that, while not perfect, is reshaping dementia research and treatment pathways.
Find the original text, and narration here on our website.
https://www.dementiaresearcher.nihr.ac.uk/blog-how-we-use-biomarkers-in-dementia-trials/
--
Marian Montanha is a Clinical Studies Office in the NHS – Neuroprogressive and Dementia Network in Scotland. With a background in Psychology and a keen interest in Neuropsychology, Marian plays a vital role in clinical research, coordinating and managing clinical trials, ensuring smooth operations, and maintaining accurate records, while also promoting research and collaborating with clinical teams. Passionate about patient care, she is driven to help people maintain dignity, independence, and quality of life. Marian's top tip for ECRs? “You don’t know what you don’t know”. Find Marian on LinkedIn
--
Enjoy listening? We're always looking for new bloggers, drop us a line. http://www.dementiaresearcher.nihr.ac.uk
This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support.
--
Follow us on Social Media:
Join our community: